AZ's Lynparza Shines Again In Prostate Cancer Study

PARP Inhibitor Improves Overall Survival

 
• By Kevin Grogan
Jigsaw_Pieces
If approved, prostate cancer would be the fourth indication for Lynparza • Source: Shutterstock

More from Anticancer

More from Therapy Areas